Combination therapy with IL-15 superagonist (ALT-803) and PD-1 blockade enhances human NK cell immunotherapy against ovarian cancer

Authors :: Charles J. Ryan
R. Isaksson Vogel
Alexander J. Lenvik
Sami Chu
Jeffrey S. Miller
Melissa A. Geller
Martin Felices
L.A. Bendzick
Kristin L.M. Boylan
Amy P.N. Skubitz
Source :: Gynecologic Oncology. 145:19
Publication Year :: 2017
Publisher :: Elsevier BV, 2017.

Subjects :: 0301 basic medicine
Combination therapy
business.industry
medicine.medical_treatment
Cell
Obstetrics and Gynecology
Immunotherapy
medicine.disease
03 medical and health sciences
030104 developmental biology
medicine.anatomical_structure
Oncology
Interleukin 15
Immunology
medicine
Cancer research
Pd 1 blockade
business
Ovarian cancer

Full Text Access

Tools